We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+5.23%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
AUM
$110M
AUM Growth
+$10.3M
Cap. Flow
+$6.19M
Cap. Flow %
5.63%
Top 10 Hldgs %
39.83%
Holding
76
New
22
Increased
18
Reduced
15
Closed
9

Top Buys

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$1.81M
2
HZO icon
MarineMax
HZO
+$1.77M
3
WGO icon
Winnebago Industries
WGO
+$1.31M
4
PFE icon
Pfizer
PFE
+$1.05M
5
CGNT icon
Cognyte Software
CGNT
+$984K

Top Sells

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$2.65M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.48M
3
CYTK icon
Cytokinetics
CYTK
+$1.61M
4
ARKO icon
ARKO Corp
ARKO
+$1.53M
5
COHU icon
Cohu
COHU
+$1.35M

Sector Composition

Rank Sector Weight
1 Healthcare 31.09%
2 Technology 10.92%
3 Materials 10.24%
4 Financials 10.01%
5 Industrials 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALCO icon
1
Alico
ALCO
$300M
$7.35M 6.7%
225,000
TGB
2
Trekor Metals
TGB
$3.36B
$7.25M 6.6%
2,300,000
-150,000
-6% -$351K
RIGL icon
3
Rigel Pharmaceuticals
RIGL
$868M
$4.68M 4.26%
250,000
RLGT icon
4
Radiant Logistics
RLGT
$408M
$4.56M 4.15%
750,000
-25,000
-3% -$150K
PLPC icon
5
Preformed Line Products
PLPC
$1.98B
$4.47M 4.08%
28,000
BGC icon
6
BGC Group
BGC
$5.76B
$3.58M 3.26%
350,000
+50,000
+17% +$459K
NMRK icon
7
Newmark Group
NMRK
$2.87B
$3.34M 3.04%
275,000
INTT icon
8
inTEST
INTT
$142M
$3.06M 2.79%
420,594
+45,594
+12% +$289K
WBD icon
9
Warner Bros
WBD
$72.1B
$2.87M 2.61%
250,000
+100,000
+67% +$933K
FOLD
10
DELISTED
Amicus Therapeutics
FOLD
$2.58M 2.35%
450,000
TALO icon
11
Talos Energy
TALO
$2.78B
$2.54M 2.32%
300,000
-50,000
-14% -$401K
SABR icon
12
Sabre
SABR
$888M
$2.53M 2.3%
800,000
+100,000
+14% +$256K
CLPT icon
13
ClearPoint Neuro
CLPT
$474M
$2.39M 2.17%
200,000
+25,000
+14% +$315K
RBCAA icon
14
Republic Bancorp
RBCAA
$1.86B
$2.34M 2.13%
32,000
-3,000
-9% -$205K
ARKO icon
15
ARKO Corp
ARKO
$490M
$2.33M 2.12%
700,000
-350,000
-33% -$1.53M
PK icon
16
Park Hotels & Resorts
PK
$3.19B
$2.3M 2.1%
225,000
+25,000
+13% +$255K
VTRS icon
17
Viatris
VTRS
$18.8B
$2.23M 2.03%
250,000
+25,000
+11% +$211K
OGN icon
18
Organon & Co
OGN
$3.61B
$2.18M 1.98%
225,000
+75,000
+50% +$774K
HZO icon
19
MarineMax
HZO
$1.15B
$2.01M 1.83%
+80,000
New +$1.77M
CGAU
20
Centerra Gold
CGAU
$4.59B
$1.98M 1.81%
275,000
-75,000
-21% -$513K
BRKL
21
DELISTED
Brookline Bancorp
BRKL
$1.9M 1.73%
180,000
IQV icon
22
IQVIA
IQV
$43.1B
$1.89M 1.72%
+12,000
New +$1.81M
ARKR icon
23
Ark Restaurants
ARKR
$19.8M
$1.8M 1.64%
200,000
AVIR icon
24
Atea Pharmaceuticals
AVIR
$430M
$1.8M 1.64%
500,000
CHRS icon
25
Coherus Oncology
CHRS
$218M
$1.65M 1.5%
2,250,000
+102,500
+5% +$88.5K

Similar funds

CM Management's Q2 2025 Portfolio in Review

As of Q2 2025, CM Management held 76 positions worth $110M, up 10% from $99.5M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

CM Management deployed $6.19M of net new capital in Q2 2025, opening 22 new positions and adding to 18 existing holdings. Its largest new stake was IQVIA: 12,000 shares worth $1.89M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 36% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was ARKO Corp, an estimated $1.53M trimmed.

  • CM Management's largest Q2 2025 buy was IQVIA: 12,000 shares worth $1.89M.
  • CM Management added most to Warner Bros in Q2 2025, an estimated $933K increase.
  • CM Management's biggest Q2 2025 reduction was ARKO Corp, cutting an estimated $1.53M.
  • CM Management fully exited Freeport-McMoran in Q2 2025, selling an estimated $2.65M.
  • CM Management's ten largest holdings make up 40% of its $110M portfolio in Q2 2025.
  • CM Management opened 22 new positions and closed 9 in Q2 2025.
  • CM Management's portfolio value rose 10% quarter-over-quarter to $110M.

Based on CM Management's 13F filing for Q2 2025, filed 12 Aug 2025.